MeyeonParkMDMAS

Nephrology • San Francisco, CA

Hereditary Kidney Disease Genetics, Hypertension

Associate Professor in Residence, Clinical Researcher, Director of UCSF PKD Center of Excellence

Join to view full profile

Dr. Park is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Park's full profile

Already have an account?

Office
500 Parnassus Ave
Division Of Nephrology, MUW 418, Box 0532
San Francisco, CA 94143
Phone+1 415-476-2173

Fax+1 415-476-3381

Summary

Dr. Meyeon Park is a nephrologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center and San Francisco VA Medical Center. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 11 years. She specializes in glomerular disease, hereditary kidney disease genetics, and hypertension and is experienced in hypertension, acute renal failure, chronic kidney disease, glomerular disease, and polycystic kidney disease.

Education & Training

University of California, San FranciscoMAS, Training in Clinical Research Program, 2010 - 2012
University of California (San Francisco)Fellowship, Nephrology, 2009 - 2012
Yale-New Haven Medical CenterResidency, Internal Medicine, 2006 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Harvard UniversityAB, Biology, Magna Cum Laude, 1998 - 2002

Certifications & Licensure

CA State Medical License 2009 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Physician Gratitude Award Polycystic Kidney Disease Foundation, 2017
Essential Core Teaching Award for Excellence in Small Group Instruction UCSF School of Medicine Classes of 2016 and 2017, 2014
Kaiser Award for Excellence in Teaching Nominee UCSF School of Medicine, 2013, 2015
Top Oral Abstract Award American Society of Nephrology, 2013
Northwestern Cardiovascular Young Investigators' Forum Clinical Research Award (3rd Place) Northwestern School of Medicine, 2013
Essential Core Teaching Award Nominee UCSF School of Medicine, 2012, 2015
Andy I. Choi, M.D. Memorial Scholarship UCSF Division of Nephrology, 2011
Nephrology Division Clinical Fellow Award UCSF Department of Medicine, 2010
Samuel D. Kushlan, M.D. Award Yale University Internal Medicine, 2007
Russell J. Stumacher, M.D. Memorial Prize University of Pennsylvania, 2006
Medical Student Research Program Award American Society of Hematology, 2003
Research Program Fellowship Harvard College, 2002
Faculty Aide Program Award Harvard College, 2001
Join now to see all

Clinical Trials

Genetic Testing in Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2023 Jun 01
Recruiting
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

1 citations
Initial Experience of Metabolic Imaging with Hyperpolarized [1-C]pyruvate MRI in Kidney Transplant Patients.
Xiaoxi Liu, Ying-Chieh Lai, Di Cui, Shiang-Cheng Kung, Meyeon Park
Arxiv. 2024-09-10
Initial Experience of Metabolic Imaging With Hyperpolarized [1-C]pyruvate MRI in Kidney Transplant Patients.
Xiaoxi Liu, Ying-Chieh Lai, Di Cui, Shiang-Cheng Kung, Meyeon Park
Journal of Magnetic Resonance Imaging. 2024-09-06
1 citations
Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.
Elise Hoover, Vanessa Holliday, Nicole Merullo, Dorothee Oberdhan, Ronald D Perrone
Kidney Medicine. 2024-05-01

Journal Articles

Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial
Daniel E Weiner, Meyeon Park, Alin A Joseph, Nitender Goyal, Chi-Yuan Hsu, Clifton E Kew, Todd E Pesavento, Andrew S Levey, American Journal of Kidney Diseases
Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial
Park M, Katz R, Shlipak MG, Weiner D, Tracy R, Jotwani V, Hughes-Austin J, Gabbai F, Hsu CY, Pfeffer M, Bansal N, Bostom A, Gutierrez O, Sarnak M, Levey A, Ix JH, Am J Transplant, 1/1/2017
Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) Consortium Association of Peak Changes in Plasma Cystatin C and Creatinine...
Park M, Shlipak MG, Thiessen-Philbrook H, Garg AX, Koyner JL, Coca SG, Parikh CR, Ann Thorac Surg, 1/1/2016
Prevalence of abdominal aortic calcifications in older living renal donors and its effect on graft function and histology
Wu EH, Wojciechowski D, Chandran S, Yeh BM, Park M, Westphalen A, Wang ZJ, Transpl Int, 1/1/2015
Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy
Park M, Liu GT, Piltz-Seymour J, et al, Leuk Lymphoma, 1/1/2007
Management of Preeclampsia
Park M, Brewster U, Hospital Physician, 1/1/2007
Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study
Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR,..., Clin J Am Soc Nephrol, 1/2./2017
Join now to see all

Lectures

Novel Therapeutics in CKD: What Is on the Horizon?
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/8/2019
A Case-Based Approach to Acute Kidney Injury
2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019